Updates on a $1M Deal: And other sweet reasons Hope Bio is thriving in Sugar Land
- Jan Shultis, Ph.D.
- 1 day ago
- 4 min read
By Jan Shultis, PhD
Welcome to Hope Bio’s newly renovated home (keep reading for construction updates and pictures)! In the third and final part of our “location, location, location” series, let’s talk about why Hope Bio is thriving in Sugar Land, Texas. New here? Click here to read part one, about how headquartering in the United States affects your access to cellular therapeutics, with emphasis on manufacturing and research standards. Click here for part two, to dive into how and why choosing Texas matters to our work and your healthcare.
The final “location” consideration is hyperlocal – within the greater Houston area, how and why Hope Biosciences chose Sugar Land, Texas, as our permanent flagship location. While county and city regulations do not affect regulatory access to cellular therapeutics like the biologics we manufacture, hyperlocal policies do affect the fiscal, operational, and logistical outlook of companies in ways that directly support your access to Hope and our access to you.
What’s most exciting to us, this year? Read all the way to the end for an update on Hope Biosciences’ progress on a million-dollar deal with the city announced in the opening weeks of 2026.
The County
Sugar Land is located west of Houston and is part of Fort Bend County, among the most diverse counties in the nation. The County proudly touts “top 10” rankings in diversity and culture indexes following the 2020 census, and again in 2026 by rater Niche. Though urban planning reports include notable challenges, and nowhere is a link between diversity and research or biotechnology explicitly made, residents seem pervasively proud of diversity status.
Diversity matters to patient recruiting, and lack of diversity in clinical research is a well-documented problem in the sector today. Despite federal and state-level efforts over the last decade to make progress, homogenous patient populations continue to be a noticeable shortcoming in therapeutic development. The void is depressingly ironic, because underrepresented racial and ethnic groups, in particular, carry a disproportionately high disease burden in many chronic conditions. As expressed in a 2022 report by the National Academies of Sciences, Engineering, and Medicine, and later used as an opening line in a 2025 follow-on report by the same, “an equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study.” The body went on to conclude in both 2022 and 2025 that the sector remains, however, “far from achieving this goal” (See 2022’s Improving Representation
Underrepresented Groups, National Academy). Patient diversity is also vital to overall drug development, because a diverse group increases the manufacturer’s potential for generalizing therapeutics in ways that can help all people in need.
Among other rationale, patients in underrepresented groups often cite barriers to participation in clinical research that include poor awareness of opportunities to participate in research, and/or logistical challenges such as lack of transportation or inflexible work schedules. Headquartering in Fort Bend, with dense population and diverse communities, as well as ample access to public transportation and other resources, creates a powerful opportunity to make progress in both of these areas. On the subject of transportation, the County’s growing infrastructure, especially rapidly expanding public transport options, also support Hope Bio’s ability to move products within the greater Houston area by hand, or easily ship them to other parts of the United States (fast fact: Hope Bio’s proprietary cellular therapeutics have proven viability for an unprecedented amount of time, meaning we can dispatch fresh treatments within about a five-day window; i.e., with confidence anywhere in the contiguous United States).
The City
We have written before about Hope Biosciences’ appreciation for Sugar Land’s family-friendly culture, including access to housing, shopping, nature, and countless amenities. The city is consistently ranked among the top in the state and nation for livability, quality of life, safety, business support, and cultural and ethnic diversity. Though our appreciation is long-standing, over the last calendar year Hope Bio’s relationship with Sugar Land has been significantly enriched. Late in 2025, Hope Biosciences pursued purchase of the building we previously leased, definitively committing to Sugar Land for the long term.
Early in 2026, historic levels of support from Sugar Land’s Economic Development Council (EDC) validated Hope Bio’s scalability, pushing forward building and team expansion, and offering a strong example of how location influences the fiscal sustainability of businesses in all industries. The agreement outlines a $1 million incentive payable to Hope Biosciences over the course of five years ($200,000 annually). Hope Biosciences will invest an additional $2 million in building improvements and equipment and create 15 new jobs over the next five years (average annual salary of $61,240).
Hope Biosciences is moving decisively in the first months of the EDC agreement. The building continues to undergo extensive renovations, including but not limited to doubling the size of the infusion suite, adding work spaces for our growing team, beautifying everything from landscaping to balconies, and improving all the maintenance elements that are familiar to any homeowner. Construction is on track for a fall completion, and work has continued unimpeded throughout the process, with phased rollout and utilization of each space as improvements are complete. Cumulatively, building improvements result in dramatically increased capacity to bank more stem cells, produce more treatments, serve more people on-site, and ship more cells throughout the United States. Hiring will begin soon to identify the 15 new team members outlined in the city agreement.
Vision, coming to life in construction at Hope Bio.
We look forward to much, much more to come. Hope Biosciences remains grateful to be American, thrilled to be in Texas and Houston, and excited about our future in Sugar Land.
Comments